Codes ATC:
P01CB01
EMLc
Indication
Cutaneous leishmaniasis
Code ICD11:
1F54.1
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IM:
1.5 g per 5 mL in 5 mL ampoule
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listing for sodium stibogluconate / meglumine antimoniate on the EML and EMLc be amended to list each medicine separately with updated dosage form descriptions as follows:
Sodium stibogluconate: Injection: 100 mg/mL in 30 mL vial
Meglumine antimoniate: Injection: 1.5 g/5 mL in 5 mL ampoule